Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Nov 6, 2013 goldstein joseph l Director Sell 1,000 300.74
Sep 19, 2013 vagelos p roy Officer Automatic Sell 145,356 300.34 - 310.18
Sep 19, 2013 schleifer leonard s Officer Automatic Sell 102,949 300.33 - 310.14
Mar 28, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 300.28 - 315.33
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Jan 14, 2014 gilman alfred g Director Automatic Sell 5,000 300.00
Mar 24, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 299.01 - 314.22
Jul 2, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 298.91 - 311.92
Sep 18, 2013 van plew daniel p Officer Automatic Sell 23,977 298.28 - 308.26
May 22, 2014 van plew daniel p Officer Disposition (Non Open Market) 5,831 296.19
Dec 2, 2013 vagelos p roy Officer Sell 95 296.11
May 19, 2014 sanofi Beneficial Owner (10% or more) Buy 190,751 296.08 - 302.70
May 23, 2014 van plew daniel p Officer Sell 5,369 295.33 - 296.70
Nov 26, 2013 sing george l Director Sell 10,000 295.00
Sep 17, 2013 van plew daniel p Officer Automatic Sell 28,523 294.75
Sep 25, 2013 brown michael s Director Automatic Sell 5,000 292.60 - 296.00
May 21, 2014 poon christine a Director Buy 255 291.90
Jan 14, 2014 mccorkle douglas s Officer Automatic Sell 4,000 290.00
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Jul 1, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 285.89 - 304.01
Showing 121-140 of 920 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)